Background Myocardial fibrosis is a key mechanism of left ventricular decompensation in
aortic stenosis and can be quantified using cardiovascular magnetic resonance (CMR) …

Objectives: Cardiac magnetic resonance (CMR) was used to investigate the extracellular
compartment and myocardial fibrosis in patients with aortic stenosis, as well as their …

Aims Haemodynamics alone do not fully explain symptoms and prognosis in clinically
severe aortic stenosis (AS). Myocardial disease, specifically diffuse myocardial fibrosis …

Aims (i) To establish the test–retest reproducibility of myocardial T1 and extracellular volume
(ECV) fraction measurement in asymptomatic patients with moderate–severe aortic stenosis …

Background Cardiovascular magnetic resonance (CMR) is the gold standard non-invasive
method for determining left ventricular (LV) mass and volume but has not been used …

Background: Left ventricular (LV) hypertrophy, a key process in human cardiac disease,
results from cellular (hypertrophy) and extracellular matrix expansion (interstitial fibrosis) …

Aortic stenosis is characterized both by progressive valve narrowing and the left ventricular
remodeling response that ensues. The only effective treatment is aortic valve replacement …

Objectives: This study assessed diffuse myocardial fibrosis (MF) by cardiac magnetic
resonance (CMR) imaging and speckle-tracking echocardiography (STE) in patients with …

Aims Midwall myocardial fibrosis on cardiovascular magnetic resonance (CMR) is a marker
of early ventricular decompensation and adverse outcomes in aortic stenosis (AS). We …

Background: Aortic stenosis is accompanied by progressive left ventricular hypertrophy and
fibrosis. We investigated the natural history of these processes in asymptomatic patients and …